| 摘要 |
The present invention is directed to benzothiophene compositions, preferably nanoparticulate raloxifene hydrochloride compositions, having improved pharmacokinetic profiles, improved bioavailability, dissolution rates and efficacy. In one embodiment, the raloxifene hydrochloride nanoparticulate composition have an effective average particle size of less than about 2000 nm.
|
